0001019056-23-000351.txt : 20230914
0001019056-23-000351.hdr.sgml : 20230914
20230914163700
ACCESSION NUMBER: 0001019056-23-000351
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230912
FILED AS OF DATE: 20230914
DATE AS OF CHANGE: 20230914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shaker Benjamin
CENTRAL INDEX KEY: 0001855843
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40332
FILM NUMBER: 231255569
MAIL ADDRESS:
STREET 1: C/O AGILON HEALTH, INC.
STREET 2: 6210 E HWY 290, SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: agilon health, inc.
CENTRAL INDEX KEY: 0001831097
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 371915147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
BUSINESS PHONE: 562-256-3800
MAIL ADDRESS:
STREET 1: 6210 E HWY 290
STREET 2: SUITE 450
CITY: AUSTIN
STATE: TX
ZIP: 78723
FORMER COMPANY:
FORMER CONFORMED NAME: Agilon Health Topco, Inc.
DATE OF NAME CHANGE: 20201103
4
1
shaker.xml
X0508
4
2023-09-12
0
0001831097
agilon health, inc.
AGL
0001855843
Shaker Benjamin
C/O AGILON HEALTH, INC.
6210 E HWY 290, SUITE 450
AUSTIN
TX
78723
0
1
0
0
Chief Markets Officer
1
Common Stock
2023-09-12
4
M
0
18750
3.79
A
98293
D
Common Stock
2023-09-12
4
S
0
18750
18.0523
D
79543
D
Common Stock
2023-09-13
4
M
0
18750
3.79
A
98293
D
Common Stock
2023-09-13
4
S
0
18750
17.9976
D
79543
D
Options (Right to buy)
3.79
2023-09-12
4
M
0
18750
0
D
2029-02-09
Common Stock
18750
320601
D
Options (Right to buy)
3.79
2023-09-13
4
M
0
18750
0
D
2029-02-09
Common Stock
18750
301851
D
Includes restricted stock units.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.67 to $18.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
These options were granted on February 9, 2019, and became fully vested as of February 9, 2023.
/s/ Steve Meetre, as Attorney-in-Fact
2023-09-14